Global Pharmaceutical OEM and ODM Supply, Demand and Key Producers, 2023-2029
The global Pharmaceutical OEM and ODM market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Pharmaceutical OEM and ODM demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical OEM and ODM, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical OEM and ODM that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical OEM and ODM total market, 2018-2029, (USD Million)
Global Pharmaceutical OEM and ODM total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical OEM and ODM total market, key domestic companies and share, (USD Million)
Global Pharmaceutical OEM and ODM revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical OEM and ODM total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical OEM and ODM total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Pharmaceutical OEM and ODM market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include JPS Pharmaceutical, New-In CO., Ltd., Kosei Pharmaceutical Co., Ltd., CD Formulation, DENKEN GROUP, PIM Pharmaceuticals, IL Myeong Pharmaceutical Co., Ltd., Kolmar Korea and Synmosa, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical OEM and ODM market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pharmaceutical OEM and ODM Market, By Region:
1. How big is the global Pharmaceutical OEM and ODM market?
2. What is the demand of the global Pharmaceutical OEM and ODM market?
3. What is the year over year growth of the global Pharmaceutical OEM and ODM market?
4. What is the total value of the global Pharmaceutical OEM and ODM market?
5. Who are the major players in the global Pharmaceutical OEM and ODM market?
This report studies the global Pharmaceutical OEM and ODM demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical OEM and ODM, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical OEM and ODM that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical OEM and ODM total market, 2018-2029, (USD Million)
Global Pharmaceutical OEM and ODM total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Pharmaceutical OEM and ODM total market, key domestic companies and share, (USD Million)
Global Pharmaceutical OEM and ODM revenue by player and market share 2018-2023, (USD Million)
Global Pharmaceutical OEM and ODM total market by Type, CAGR, 2018-2029, (USD Million)
Global Pharmaceutical OEM and ODM total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Pharmaceutical OEM and ODM market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include JPS Pharmaceutical, New-In CO., Ltd., Kosei Pharmaceutical Co., Ltd., CD Formulation, DENKEN GROUP, PIM Pharmaceuticals, IL Myeong Pharmaceutical Co., Ltd., Kolmar Korea and Synmosa, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical OEM and ODM market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pharmaceutical OEM and ODM Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Pharmaceutical OEM
- Pharmaceutical ODM
- Traditional Chinese Medicine
- Western Medicine
- Biologics
- Others
- JPS Pharmaceutical
- New-In CO., Ltd.
- Kosei Pharmaceutical Co., Ltd.
- CD Formulation
- DENKEN GROUP
- PIM Pharmaceuticals
- IL Myeong Pharmaceutical Co., Ltd.
- Kolmar Korea
- Synmosa
- Itoh Kanpo Pharmaceutical Co., Ltd.
- Hanso Pharmaceutical
- Dr.Japan Co., Ltd.
- Guangdong Qingyunshan Pharmaceutical Co.,Ltd.
- Weidar Chemical & Pharmaceutical Co., Ltd.
- Tianjin Hezhi Pharmaceutical Group Co., Ltd.
1. How big is the global Pharmaceutical OEM and ODM market?
2. What is the demand of the global Pharmaceutical OEM and ODM market?
3. What is the year over year growth of the global Pharmaceutical OEM and ODM market?
4. What is the total value of the global Pharmaceutical OEM and ODM market?
5. Who are the major players in the global Pharmaceutical OEM and ODM market?
1 SUPPLY SUMMARY
1.1 Pharmaceutical OEM and ODM Introduction
1.2 World Pharmaceutical OEM and ODM Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pharmaceutical OEM and ODM Total Market by Region (by Headquarter Location)
1.3.1 World Pharmaceutical OEM and ODM Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pharmaceutical OEM and ODM Market Size (2018-2029)
1.3.3 China Pharmaceutical OEM and ODM Market Size (2018-2029)
1.3.4 Europe Pharmaceutical OEM and ODM Market Size (2018-2029)
1.3.5 Japan Pharmaceutical OEM and ODM Market Size (2018-2029)
1.3.6 South Korea Pharmaceutical OEM and ODM Market Size (2018-2029)
1.3.7 ASEAN Pharmaceutical OEM and ODM Market Size (2018-2029)
1.3.8 India Pharmaceutical OEM and ODM Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical OEM and ODM Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical OEM and ODM Major Market Trends
2 DEMAND SUMMARY
2.1 World Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.2 World Pharmaceutical OEM and ODM Consumption Value by Region
2.2.1 World Pharmaceutical OEM and ODM Consumption Value by Region (2018-2023)
2.2.2 World Pharmaceutical OEM and ODM Consumption Value Forecast by Region (2024-2029)
2.3 United States Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.4 China Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.5 Europe Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.6 Japan Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.7 South Korea Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.8 ASEAN Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.9 India Pharmaceutical OEM and ODM Consumption Value (2018-2029)
3 WORLD PHARMACEUTICAL OEM AND ODM COMPANIES COMPETITIVE ANALYSIS
3.1 World Pharmaceutical OEM and ODM Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pharmaceutical OEM and ODM Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical OEM and ODM in 2022
3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical OEM and ODM in 2022
3.3 Pharmaceutical OEM and ODM Company Evaluation Quadrant
3.4 Pharmaceutical OEM and ODM Market: Overall Company Footprint Analysis
3.4.1 Pharmaceutical OEM and ODM Market: Region Footprint
3.4.2 Pharmaceutical OEM and ODM Market: Company Product Type Footprint
3.4.3 Pharmaceutical OEM and ODM Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pharmaceutical OEM and ODM Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pharmaceutical OEM and ODM Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pharmaceutical OEM and ODM Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pharmaceutical OEM and ODM Consumption Value Comparison
4.2.1 United States VS China: Pharmaceutical OEM and ODM Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pharmaceutical OEM and ODM Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pharmaceutical OEM and ODM Companies and Market Share, 2018-2023
4.3.1 United States Based Pharmaceutical OEM and ODM Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pharmaceutical OEM and ODM Revenue, (2018-2023)
4.4 China Based Companies Pharmaceutical OEM and ODM Revenue and Market Share, 2018-2023
4.4.1 China Based Pharmaceutical OEM and ODM Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pharmaceutical OEM and ODM Revenue, (2018-2023)
4.5 Rest of World Based Pharmaceutical OEM and ODM Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pharmaceutical OEM and ODM Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pharmaceutical OEM and ODM Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical OEM and ODM Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Pharmaceutical OEM
5.2.2 Pharmaceutical ODM
5.3 Market Segment by Type
5.3.1 World Pharmaceutical OEM and ODM Market Size by Type (2018-2023)
5.3.2 World Pharmaceutical OEM and ODM Market Size by Type (2024-2029)
5.3.3 World Pharmaceutical OEM and ODM Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharmaceutical OEM and ODM Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Traditional Chinese Medicine
6.2.2 Western Medicine
6.2.3 Biologics
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Pharmaceutical OEM and ODM Market Size by Application (2018-2023)
6.3.2 World Pharmaceutical OEM and ODM Market Size by Application (2024-2029)
6.3.3 World Pharmaceutical OEM and ODM Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 JPS Pharmaceutical
7.1.1 JPS Pharmaceutical Details
7.1.2 JPS Pharmaceutical Major Business
7.1.3 JPS Pharmaceutical Pharmaceutical OEM and ODM Product and Services
7.1.4 JPS Pharmaceutical Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 JPS Pharmaceutical Recent Developments/Updates
7.1.6 JPS Pharmaceutical Competitive Strengths & Weaknesses
7.2 New-In CO., Ltd.
7.2.1 New-In CO., Ltd. Details
7.2.2 New-In CO., Ltd. Major Business
7.2.3 New-In CO., Ltd. Pharmaceutical OEM and ODM Product and Services
7.2.4 New-In CO., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 New-In CO., Ltd. Recent Developments/Updates
7.2.6 New-In CO., Ltd. Competitive Strengths & Weaknesses
7.3 Kosei Pharmaceutical Co., Ltd.
7.3.1 Kosei Pharmaceutical Co., Ltd. Details
7.3.2 Kosei Pharmaceutical Co., Ltd. Major Business
7.3.3 Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
7.3.4 Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Kosei Pharmaceutical Co., Ltd. Recent Developments/Updates
7.3.6 Kosei Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.4 CD Formulation
7.4.1 CD Formulation Details
7.4.2 CD Formulation Major Business
7.4.3 CD Formulation Pharmaceutical OEM and ODM Product and Services
7.4.4 CD Formulation Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 CD Formulation Recent Developments/Updates
7.4.6 CD Formulation Competitive Strengths & Weaknesses
7.5 DENKEN GROUP
7.5.1 DENKEN GROUP Details
7.5.2 DENKEN GROUP Major Business
7.5.3 DENKEN GROUP Pharmaceutical OEM and ODM Product and Services
7.5.4 DENKEN GROUP Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 DENKEN GROUP Recent Developments/Updates
7.5.6 DENKEN GROUP Competitive Strengths & Weaknesses
7.6 PIM Pharmaceuticals
7.6.1 PIM Pharmaceuticals Details
7.6.2 PIM Pharmaceuticals Major Business
7.6.3 PIM Pharmaceuticals Pharmaceutical OEM and ODM Product and Services
7.6.4 PIM Pharmaceuticals Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 PIM Pharmaceuticals Recent Developments/Updates
7.6.6 PIM Pharmaceuticals Competitive Strengths & Weaknesses
7.7 IL Myeong Pharmaceutical Co., Ltd.
7.7.1 IL Myeong Pharmaceutical Co., Ltd. Details
7.7.2 IL Myeong Pharmaceutical Co., Ltd. Major Business
7.7.3 IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
7.7.4 IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 IL Myeong Pharmaceutical Co., Ltd. Recent Developments/Updates
7.7.6 IL Myeong Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.8 Kolmar Korea
7.8.1 Kolmar Korea Details
7.8.2 Kolmar Korea Major Business
7.8.3 Kolmar Korea Pharmaceutical OEM and ODM Product and Services
7.8.4 Kolmar Korea Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Kolmar Korea Recent Developments/Updates
7.8.6 Kolmar Korea Competitive Strengths & Weaknesses
7.9 Synmosa
7.9.1 Synmosa Details
7.9.2 Synmosa Major Business
7.9.3 Synmosa Pharmaceutical OEM and ODM Product and Services
7.9.4 Synmosa Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Synmosa Recent Developments/Updates
7.9.6 Synmosa Competitive Strengths & Weaknesses
7.10 Itoh Kanpo Pharmaceutical Co., Ltd.
7.10.1 Itoh Kanpo Pharmaceutical Co., Ltd. Details
7.10.2 Itoh Kanpo Pharmaceutical Co., Ltd. Major Business
7.10.3 Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
7.10.4 Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Itoh Kanpo Pharmaceutical Co., Ltd. Recent Developments/Updates
7.10.6 Itoh Kanpo Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.11 Hanso Pharmaceutical
7.11.1 Hanso Pharmaceutical Details
7.11.2 Hanso Pharmaceutical Major Business
7.11.3 Hanso Pharmaceutical Pharmaceutical OEM and ODM Product and Services
7.11.4 Hanso Pharmaceutical Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Hanso Pharmaceutical Recent Developments/Updates
7.11.6 Hanso Pharmaceutical Competitive Strengths & Weaknesses
7.12 Dr.Japan Co., Ltd.
7.12.1 Dr.Japan Co., Ltd. Details
7.12.2 Dr.Japan Co., Ltd. Major Business
7.12.3 Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Product and Services
7.12.4 Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Dr.Japan Co., Ltd. Recent Developments/Updates
7.12.6 Dr.Japan Co., Ltd. Competitive Strengths & Weaknesses
7.13 Guangdong Qingyunshan Pharmaceutical Co.,Ltd.
7.13.1 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Details
7.13.2 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Major Business
7.13.3 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Product and Services
7.13.4 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.13.6 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
7.14 Weidar Chemical & Pharmaceutical Co., Ltd.
7.14.1 Weidar Chemical & Pharmaceutical Co., Ltd. Details
7.14.2 Weidar Chemical & Pharmaceutical Co., Ltd. Major Business
7.14.3 Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
7.14.4 Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Weidar Chemical & Pharmaceutical Co., Ltd. Recent Developments/Updates
7.14.6 Weidar Chemical & Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.15 Tianjin Hezhi Pharmaceutical Group Co., Ltd.
7.15.1 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Details
7.15.2 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Major Business
7.15.3 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Product and Services
7.15.4 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Recent Developments/Updates
7.15.6 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pharmaceutical OEM and ODM Industry Chain
8.2 Pharmaceutical OEM and ODM Upstream Analysis
8.3 Pharmaceutical OEM and ODM Midstream Analysis
8.4 Pharmaceutical OEM and ODM Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Pharmaceutical OEM and ODM Introduction
1.2 World Pharmaceutical OEM and ODM Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Pharmaceutical OEM and ODM Total Market by Region (by Headquarter Location)
1.3.1 World Pharmaceutical OEM and ODM Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Pharmaceutical OEM and ODM Market Size (2018-2029)
1.3.3 China Pharmaceutical OEM and ODM Market Size (2018-2029)
1.3.4 Europe Pharmaceutical OEM and ODM Market Size (2018-2029)
1.3.5 Japan Pharmaceutical OEM and ODM Market Size (2018-2029)
1.3.6 South Korea Pharmaceutical OEM and ODM Market Size (2018-2029)
1.3.7 ASEAN Pharmaceutical OEM and ODM Market Size (2018-2029)
1.3.8 India Pharmaceutical OEM and ODM Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical OEM and ODM Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical OEM and ODM Major Market Trends
2 DEMAND SUMMARY
2.1 World Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.2 World Pharmaceutical OEM and ODM Consumption Value by Region
2.2.1 World Pharmaceutical OEM and ODM Consumption Value by Region (2018-2023)
2.2.2 World Pharmaceutical OEM and ODM Consumption Value Forecast by Region (2024-2029)
2.3 United States Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.4 China Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.5 Europe Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.6 Japan Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.7 South Korea Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.8 ASEAN Pharmaceutical OEM and ODM Consumption Value (2018-2029)
2.9 India Pharmaceutical OEM and ODM Consumption Value (2018-2029)
3 WORLD PHARMACEUTICAL OEM AND ODM COMPANIES COMPETITIVE ANALYSIS
3.1 World Pharmaceutical OEM and ODM Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pharmaceutical OEM and ODM Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pharmaceutical OEM and ODM in 2022
3.2.3 Global Concentration Ratios (CR8) for Pharmaceutical OEM and ODM in 2022
3.3 Pharmaceutical OEM and ODM Company Evaluation Quadrant
3.4 Pharmaceutical OEM and ODM Market: Overall Company Footprint Analysis
3.4.1 Pharmaceutical OEM and ODM Market: Region Footprint
3.4.2 Pharmaceutical OEM and ODM Market: Company Product Type Footprint
3.4.3 Pharmaceutical OEM and ODM Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pharmaceutical OEM and ODM Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pharmaceutical OEM and ODM Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Pharmaceutical OEM and ODM Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Pharmaceutical OEM and ODM Consumption Value Comparison
4.2.1 United States VS China: Pharmaceutical OEM and ODM Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pharmaceutical OEM and ODM Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Pharmaceutical OEM and ODM Companies and Market Share, 2018-2023
4.3.1 United States Based Pharmaceutical OEM and ODM Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pharmaceutical OEM and ODM Revenue, (2018-2023)
4.4 China Based Companies Pharmaceutical OEM and ODM Revenue and Market Share, 2018-2023
4.4.1 China Based Pharmaceutical OEM and ODM Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pharmaceutical OEM and ODM Revenue, (2018-2023)
4.5 Rest of World Based Pharmaceutical OEM and ODM Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Pharmaceutical OEM and ODM Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Pharmaceutical OEM and ODM Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical OEM and ODM Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Pharmaceutical OEM
5.2.2 Pharmaceutical ODM
5.3 Market Segment by Type
5.3.1 World Pharmaceutical OEM and ODM Market Size by Type (2018-2023)
5.3.2 World Pharmaceutical OEM and ODM Market Size by Type (2024-2029)
5.3.3 World Pharmaceutical OEM and ODM Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pharmaceutical OEM and ODM Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Traditional Chinese Medicine
6.2.2 Western Medicine
6.2.3 Biologics
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Pharmaceutical OEM and ODM Market Size by Application (2018-2023)
6.3.2 World Pharmaceutical OEM and ODM Market Size by Application (2024-2029)
6.3.3 World Pharmaceutical OEM and ODM Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 JPS Pharmaceutical
7.1.1 JPS Pharmaceutical Details
7.1.2 JPS Pharmaceutical Major Business
7.1.3 JPS Pharmaceutical Pharmaceutical OEM and ODM Product and Services
7.1.4 JPS Pharmaceutical Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 JPS Pharmaceutical Recent Developments/Updates
7.1.6 JPS Pharmaceutical Competitive Strengths & Weaknesses
7.2 New-In CO., Ltd.
7.2.1 New-In CO., Ltd. Details
7.2.2 New-In CO., Ltd. Major Business
7.2.3 New-In CO., Ltd. Pharmaceutical OEM and ODM Product and Services
7.2.4 New-In CO., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 New-In CO., Ltd. Recent Developments/Updates
7.2.6 New-In CO., Ltd. Competitive Strengths & Weaknesses
7.3 Kosei Pharmaceutical Co., Ltd.
7.3.1 Kosei Pharmaceutical Co., Ltd. Details
7.3.2 Kosei Pharmaceutical Co., Ltd. Major Business
7.3.3 Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
7.3.4 Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Kosei Pharmaceutical Co., Ltd. Recent Developments/Updates
7.3.6 Kosei Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.4 CD Formulation
7.4.1 CD Formulation Details
7.4.2 CD Formulation Major Business
7.4.3 CD Formulation Pharmaceutical OEM and ODM Product and Services
7.4.4 CD Formulation Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 CD Formulation Recent Developments/Updates
7.4.6 CD Formulation Competitive Strengths & Weaknesses
7.5 DENKEN GROUP
7.5.1 DENKEN GROUP Details
7.5.2 DENKEN GROUP Major Business
7.5.3 DENKEN GROUP Pharmaceutical OEM and ODM Product and Services
7.5.4 DENKEN GROUP Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 DENKEN GROUP Recent Developments/Updates
7.5.6 DENKEN GROUP Competitive Strengths & Weaknesses
7.6 PIM Pharmaceuticals
7.6.1 PIM Pharmaceuticals Details
7.6.2 PIM Pharmaceuticals Major Business
7.6.3 PIM Pharmaceuticals Pharmaceutical OEM and ODM Product and Services
7.6.4 PIM Pharmaceuticals Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 PIM Pharmaceuticals Recent Developments/Updates
7.6.6 PIM Pharmaceuticals Competitive Strengths & Weaknesses
7.7 IL Myeong Pharmaceutical Co., Ltd.
7.7.1 IL Myeong Pharmaceutical Co., Ltd. Details
7.7.2 IL Myeong Pharmaceutical Co., Ltd. Major Business
7.7.3 IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
7.7.4 IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 IL Myeong Pharmaceutical Co., Ltd. Recent Developments/Updates
7.7.6 IL Myeong Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.8 Kolmar Korea
7.8.1 Kolmar Korea Details
7.8.2 Kolmar Korea Major Business
7.8.3 Kolmar Korea Pharmaceutical OEM and ODM Product and Services
7.8.4 Kolmar Korea Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Kolmar Korea Recent Developments/Updates
7.8.6 Kolmar Korea Competitive Strengths & Weaknesses
7.9 Synmosa
7.9.1 Synmosa Details
7.9.2 Synmosa Major Business
7.9.3 Synmosa Pharmaceutical OEM and ODM Product and Services
7.9.4 Synmosa Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Synmosa Recent Developments/Updates
7.9.6 Synmosa Competitive Strengths & Weaknesses
7.10 Itoh Kanpo Pharmaceutical Co., Ltd.
7.10.1 Itoh Kanpo Pharmaceutical Co., Ltd. Details
7.10.2 Itoh Kanpo Pharmaceutical Co., Ltd. Major Business
7.10.3 Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
7.10.4 Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Itoh Kanpo Pharmaceutical Co., Ltd. Recent Developments/Updates
7.10.6 Itoh Kanpo Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.11 Hanso Pharmaceutical
7.11.1 Hanso Pharmaceutical Details
7.11.2 Hanso Pharmaceutical Major Business
7.11.3 Hanso Pharmaceutical Pharmaceutical OEM and ODM Product and Services
7.11.4 Hanso Pharmaceutical Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Hanso Pharmaceutical Recent Developments/Updates
7.11.6 Hanso Pharmaceutical Competitive Strengths & Weaknesses
7.12 Dr.Japan Co., Ltd.
7.12.1 Dr.Japan Co., Ltd. Details
7.12.2 Dr.Japan Co., Ltd. Major Business
7.12.3 Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Product and Services
7.12.4 Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Dr.Japan Co., Ltd. Recent Developments/Updates
7.12.6 Dr.Japan Co., Ltd. Competitive Strengths & Weaknesses
7.13 Guangdong Qingyunshan Pharmaceutical Co.,Ltd.
7.13.1 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Details
7.13.2 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Major Business
7.13.3 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Product and Services
7.13.4 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.13.6 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
7.14 Weidar Chemical & Pharmaceutical Co., Ltd.
7.14.1 Weidar Chemical & Pharmaceutical Co., Ltd. Details
7.14.2 Weidar Chemical & Pharmaceutical Co., Ltd. Major Business
7.14.3 Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
7.14.4 Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Weidar Chemical & Pharmaceutical Co., Ltd. Recent Developments/Updates
7.14.6 Weidar Chemical & Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.15 Tianjin Hezhi Pharmaceutical Group Co., Ltd.
7.15.1 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Details
7.15.2 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Major Business
7.15.3 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Product and Services
7.15.4 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Recent Developments/Updates
7.15.6 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pharmaceutical OEM and ODM Industry Chain
8.2 Pharmaceutical OEM and ODM Upstream Analysis
8.3 Pharmaceutical OEM and ODM Midstream Analysis
8.4 Pharmaceutical OEM and ODM Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Pharmaceutical OEM and ODM Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pharmaceutical OEM and ODM Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pharmaceutical OEM and ODM Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pharmaceutical OEM and ODM Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pharmaceutical OEM and ODM Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pharmaceutical OEM and ODM Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pharmaceutical OEM and ODM Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pharmaceutical OEM and ODM Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pharmaceutical OEM and ODM Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pharmaceutical OEM and ODM Players in 2022
Table 12. World Pharmaceutical OEM and ODM Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pharmaceutical OEM and ODM Company Evaluation Quadrant
Table 14. Head Office of Key Pharmaceutical OEM and ODM Player
Table 15. Pharmaceutical OEM and ODM Market: Company Product Type Footprint
Table 16. Pharmaceutical OEM and ODM Market: Company Product Application Footprint
Table 17. Pharmaceutical OEM and ODM Mergers & Acquisitions Activity
Table 18. United States VS China Pharmaceutical OEM and ODM Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pharmaceutical OEM and ODM Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pharmaceutical OEM and ODM Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pharmaceutical OEM and ODM Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pharmaceutical OEM and ODM Revenue Market Share (2018-2023)
Table 23. China Based Pharmaceutical OEM and ODM Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pharmaceutical OEM and ODM Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pharmaceutical OEM and ODM Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pharmaceutical OEM and ODM Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pharmaceutical OEM and ODM Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pharmaceutical OEM and ODM Revenue Market Share (2018-2023)
Table 29. World Pharmaceutical OEM and ODM Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pharmaceutical OEM and ODM Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pharmaceutical OEM and ODM Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pharmaceutical OEM and ODM Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pharmaceutical OEM and ODM Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pharmaceutical OEM and ODM Market Size by Application (2024-2029) & (USD Million)
Table 35. JPS Pharmaceutical Basic Information, Area Served and Competitors
Table 36. JPS Pharmaceutical Major Business
Table 37. JPS Pharmaceutical Pharmaceutical OEM and ODM Product and Services
Table 38. JPS Pharmaceutical Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. JPS Pharmaceutical Recent Developments/Updates
Table 40. JPS Pharmaceutical Competitive Strengths & Weaknesses
Table 41. New-In CO., Ltd. Basic Information, Area Served and Competitors
Table 42. New-In CO., Ltd. Major Business
Table 43. New-In CO., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 44. New-In CO., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. New-In CO., Ltd. Recent Developments/Updates
Table 46. New-In CO., Ltd. Competitive Strengths & Weaknesses
Table 47. Kosei Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 48. Kosei Pharmaceutical Co., Ltd. Major Business
Table 49. Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 50. Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Kosei Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 52. Kosei Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 53. CD Formulation Basic Information, Area Served and Competitors
Table 54. CD Formulation Major Business
Table 55. CD Formulation Pharmaceutical OEM and ODM Product and Services
Table 56. CD Formulation Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. CD Formulation Recent Developments/Updates
Table 58. CD Formulation Competitive Strengths & Weaknesses
Table 59. DENKEN GROUP Basic Information, Area Served and Competitors
Table 60. DENKEN GROUP Major Business
Table 61. DENKEN GROUP Pharmaceutical OEM and ODM Product and Services
Table 62. DENKEN GROUP Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. DENKEN GROUP Recent Developments/Updates
Table 64. DENKEN GROUP Competitive Strengths & Weaknesses
Table 65. PIM Pharmaceuticals Basic Information, Area Served and Competitors
Table 66. PIM Pharmaceuticals Major Business
Table 67. PIM Pharmaceuticals Pharmaceutical OEM and ODM Product and Services
Table 68. PIM Pharmaceuticals Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. PIM Pharmaceuticals Recent Developments/Updates
Table 70. PIM Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. IL Myeong Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 72. IL Myeong Pharmaceutical Co., Ltd. Major Business
Table 73. IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 74. IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. IL Myeong Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 76. IL Myeong Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 77. Kolmar Korea Basic Information, Area Served and Competitors
Table 78. Kolmar Korea Major Business
Table 79. Kolmar Korea Pharmaceutical OEM and ODM Product and Services
Table 80. Kolmar Korea Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Kolmar Korea Recent Developments/Updates
Table 82. Kolmar Korea Competitive Strengths & Weaknesses
Table 83. Synmosa Basic Information, Area Served and Competitors
Table 84. Synmosa Major Business
Table 85. Synmosa Pharmaceutical OEM and ODM Product and Services
Table 86. Synmosa Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Synmosa Recent Developments/Updates
Table 88. Synmosa Competitive Strengths & Weaknesses
Table 89. Itoh Kanpo Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 90. Itoh Kanpo Pharmaceutical Co., Ltd. Major Business
Table 91. Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 92. Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Itoh Kanpo Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 94. Itoh Kanpo Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 95. Hanso Pharmaceutical Basic Information, Area Served and Competitors
Table 96. Hanso Pharmaceutical Major Business
Table 97. Hanso Pharmaceutical Pharmaceutical OEM and ODM Product and Services
Table 98. Hanso Pharmaceutical Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Hanso Pharmaceutical Recent Developments/Updates
Table 100. Hanso Pharmaceutical Competitive Strengths & Weaknesses
Table 101. Dr.Japan Co., Ltd. Basic Information, Area Served and Competitors
Table 102. Dr.Japan Co., Ltd. Major Business
Table 103. Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 104. Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Dr.Japan Co., Ltd. Recent Developments/Updates
Table 106. Dr.Japan Co., Ltd. Competitive Strengths & Weaknesses
Table 107. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Basic Information, Area Served and Competitors
Table 108. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Major Business
Table 109. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Product and Services
Table 110. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 112. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
Table 113. Weidar Chemical & Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 114. Weidar Chemical & Pharmaceutical Co., Ltd. Major Business
Table 115. Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 116. Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Weidar Chemical & Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 118. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Basic Information, Area Served and Competitors
Table 119. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Major Business
Table 120. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 121. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Pharmaceutical OEM and ODM Upstream (Raw Materials)
Table 123. Pharmaceutical OEM and ODM Typical Customers
List of Figure
Figure 1. Pharmaceutical OEM and ODM Picture
Figure 2. World Pharmaceutical OEM and ODM Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pharmaceutical OEM and ODM Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pharmaceutical OEM and ODM Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pharmaceutical OEM and ODM Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 13. Pharmaceutical OEM and ODM Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pharmaceutical OEM and ODM Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 23. India Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Pharmaceutical OEM and ODM by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical OEM and ODM Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical OEM and ODM Markets in 2022
Figure 27. United States VS China: Pharmaceutical OEM and ODM Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pharmaceutical OEM and ODM Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Pharmaceutical OEM and ODM Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Pharmaceutical OEM and ODM Market Size Market Share by Type in 2022
Figure 31. Pharmaceutical OEM
Figure 32. Pharmaceutical ODM
Figure 33. World Pharmaceutical OEM and ODM Market Size Market Share by Type (2018-2029)
Figure 34. World Pharmaceutical OEM and ODM Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Pharmaceutical OEM and ODM Market Size Market Share by Application in 2022
Figure 36. Traditional Chinese Medicine
Figure 37. Western Medicine
Figure 38. Biologics
Figure 39. Others
Figure 40. Pharmaceutical OEM and ODM Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Table 1. World Pharmaceutical OEM and ODM Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Pharmaceutical OEM and ODM Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Pharmaceutical OEM and ODM Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Pharmaceutical OEM and ODM Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Pharmaceutical OEM and ODM Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pharmaceutical OEM and ODM Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Pharmaceutical OEM and ODM Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Pharmaceutical OEM and ODM Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Pharmaceutical OEM and ODM Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Pharmaceutical OEM and ODM Players in 2022
Table 12. World Pharmaceutical OEM and ODM Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Pharmaceutical OEM and ODM Company Evaluation Quadrant
Table 14. Head Office of Key Pharmaceutical OEM and ODM Player
Table 15. Pharmaceutical OEM and ODM Market: Company Product Type Footprint
Table 16. Pharmaceutical OEM and ODM Market: Company Product Application Footprint
Table 17. Pharmaceutical OEM and ODM Mergers & Acquisitions Activity
Table 18. United States VS China Pharmaceutical OEM and ODM Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Pharmaceutical OEM and ODM Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Pharmaceutical OEM and ODM Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pharmaceutical OEM and ODM Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Pharmaceutical OEM and ODM Revenue Market Share (2018-2023)
Table 23. China Based Pharmaceutical OEM and ODM Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pharmaceutical OEM and ODM Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Pharmaceutical OEM and ODM Revenue Market Share (2018-2023)
Table 26. Rest of World Based Pharmaceutical OEM and ODM Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Pharmaceutical OEM and ODM Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Pharmaceutical OEM and ODM Revenue Market Share (2018-2023)
Table 29. World Pharmaceutical OEM and ODM Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Pharmaceutical OEM and ODM Market Size by Type (2018-2023) & (USD Million)
Table 31. World Pharmaceutical OEM and ODM Market Size by Type (2024-2029) & (USD Million)
Table 32. World Pharmaceutical OEM and ODM Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Pharmaceutical OEM and ODM Market Size by Application (2018-2023) & (USD Million)
Table 34. World Pharmaceutical OEM and ODM Market Size by Application (2024-2029) & (USD Million)
Table 35. JPS Pharmaceutical Basic Information, Area Served and Competitors
Table 36. JPS Pharmaceutical Major Business
Table 37. JPS Pharmaceutical Pharmaceutical OEM and ODM Product and Services
Table 38. JPS Pharmaceutical Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. JPS Pharmaceutical Recent Developments/Updates
Table 40. JPS Pharmaceutical Competitive Strengths & Weaknesses
Table 41. New-In CO., Ltd. Basic Information, Area Served and Competitors
Table 42. New-In CO., Ltd. Major Business
Table 43. New-In CO., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 44. New-In CO., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. New-In CO., Ltd. Recent Developments/Updates
Table 46. New-In CO., Ltd. Competitive Strengths & Weaknesses
Table 47. Kosei Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 48. Kosei Pharmaceutical Co., Ltd. Major Business
Table 49. Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 50. Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Kosei Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 52. Kosei Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 53. CD Formulation Basic Information, Area Served and Competitors
Table 54. CD Formulation Major Business
Table 55. CD Formulation Pharmaceutical OEM and ODM Product and Services
Table 56. CD Formulation Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. CD Formulation Recent Developments/Updates
Table 58. CD Formulation Competitive Strengths & Weaknesses
Table 59. DENKEN GROUP Basic Information, Area Served and Competitors
Table 60. DENKEN GROUP Major Business
Table 61. DENKEN GROUP Pharmaceutical OEM and ODM Product and Services
Table 62. DENKEN GROUP Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. DENKEN GROUP Recent Developments/Updates
Table 64. DENKEN GROUP Competitive Strengths & Weaknesses
Table 65. PIM Pharmaceuticals Basic Information, Area Served and Competitors
Table 66. PIM Pharmaceuticals Major Business
Table 67. PIM Pharmaceuticals Pharmaceutical OEM and ODM Product and Services
Table 68. PIM Pharmaceuticals Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. PIM Pharmaceuticals Recent Developments/Updates
Table 70. PIM Pharmaceuticals Competitive Strengths & Weaknesses
Table 71. IL Myeong Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 72. IL Myeong Pharmaceutical Co., Ltd. Major Business
Table 73. IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 74. IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. IL Myeong Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 76. IL Myeong Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 77. Kolmar Korea Basic Information, Area Served and Competitors
Table 78. Kolmar Korea Major Business
Table 79. Kolmar Korea Pharmaceutical OEM and ODM Product and Services
Table 80. Kolmar Korea Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Kolmar Korea Recent Developments/Updates
Table 82. Kolmar Korea Competitive Strengths & Weaknesses
Table 83. Synmosa Basic Information, Area Served and Competitors
Table 84. Synmosa Major Business
Table 85. Synmosa Pharmaceutical OEM and ODM Product and Services
Table 86. Synmosa Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Synmosa Recent Developments/Updates
Table 88. Synmosa Competitive Strengths & Weaknesses
Table 89. Itoh Kanpo Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 90. Itoh Kanpo Pharmaceutical Co., Ltd. Major Business
Table 91. Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 92. Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Itoh Kanpo Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 94. Itoh Kanpo Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 95. Hanso Pharmaceutical Basic Information, Area Served and Competitors
Table 96. Hanso Pharmaceutical Major Business
Table 97. Hanso Pharmaceutical Pharmaceutical OEM and ODM Product and Services
Table 98. Hanso Pharmaceutical Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Hanso Pharmaceutical Recent Developments/Updates
Table 100. Hanso Pharmaceutical Competitive Strengths & Weaknesses
Table 101. Dr.Japan Co., Ltd. Basic Information, Area Served and Competitors
Table 102. Dr.Japan Co., Ltd. Major Business
Table 103. Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 104. Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Dr.Japan Co., Ltd. Recent Developments/Updates
Table 106. Dr.Japan Co., Ltd. Competitive Strengths & Weaknesses
Table 107. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Basic Information, Area Served and Competitors
Table 108. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Major Business
Table 109. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Product and Services
Table 110. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 112. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
Table 113. Weidar Chemical & Pharmaceutical Co., Ltd. Basic Information, Area Served and Competitors
Table 114. Weidar Chemical & Pharmaceutical Co., Ltd. Major Business
Table 115. Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 116. Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Weidar Chemical & Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 118. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Basic Information, Area Served and Competitors
Table 119. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Major Business
Table 120. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Product and Services
Table 121. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Pharmaceutical OEM and ODM Upstream (Raw Materials)
Table 123. Pharmaceutical OEM and ODM Typical Customers
List of Figure
Figure 1. Pharmaceutical OEM and ODM Picture
Figure 2. World Pharmaceutical OEM and ODM Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pharmaceutical OEM and ODM Total Market Size (2018-2029) & (USD Million)
Figure 4. World Pharmaceutical OEM and ODM Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Pharmaceutical OEM and ODM Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Pharmaceutical OEM and ODM Revenue (2018-2029) & (USD Million)
Figure 13. Pharmaceutical OEM and ODM Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 16. World Pharmaceutical OEM and ODM Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 18. China Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 23. India Pharmaceutical OEM and ODM Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Pharmaceutical OEM and ODM by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical OEM and ODM Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical OEM and ODM Markets in 2022
Figure 27. United States VS China: Pharmaceutical OEM and ODM Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pharmaceutical OEM and ODM Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Pharmaceutical OEM and ODM Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Pharmaceutical OEM and ODM Market Size Market Share by Type in 2022
Figure 31. Pharmaceutical OEM
Figure 32. Pharmaceutical ODM
Figure 33. World Pharmaceutical OEM and ODM Market Size Market Share by Type (2018-2029)
Figure 34. World Pharmaceutical OEM and ODM Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Pharmaceutical OEM and ODM Market Size Market Share by Application in 2022
Figure 36. Traditional Chinese Medicine
Figure 37. Western Medicine
Figure 38. Biologics
Figure 39. Others
Figure 40. Pharmaceutical OEM and ODM Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
